Clinical Trials Sponsored by Ourotech, Inc.
Total 35663 results
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Acrotech Biopharma Inc.Withdrawn
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
Cervel Neurotech, Inc.Completed
-
Acrotech Biopharma Inc.Active, not recruitingAtopic DermatitisUnited States
-
Acrotech Biopharma Inc.Withdrawn
-
Acrotech Biopharma Inc.CompletedCutaneous T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited Kingdom, United States
-
Acrotech Biopharma Inc.CompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, Italy
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Acrotech Biopharma Inc.CompletedAcute Lymphoblastic LeukemiaUnited States
-
Cervel Neurotech, Inc.CompletedDepressive Disorder, MajorUnited States
-
Acrotech Biopharma Inc.CompletedAtopic DermatitisUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.Completed
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
Acrotech Biopharma Inc.CompletedMultiple MyelomaUnited States
-
Acrotech Biopharma Inc.CompletedMalignant MelanomaUnited States
-
Cervel Neurotech, Inc.CompletedMajor Depressive DisorderUnited States, Australia
-
Ourotech, Inc.Imperial College Healthcare NHS TrustRecruitingGlioblastoma | Brain Tumor | Ependymoma | Oligodendroglioma | Glioma, MalignantUnited Kingdom
-
Acrotech Biopharma Inc.OnxeoCompletedStage IV Non-small Cell Lung CancerUnited States
-
Ourotech, Inc.Barts & The London NHS TrustRecruitingTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
PureTechRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Urothelial CarcinomaUnited States
-
PureTechRecruiting
-
PureTechActive, not recruitingIdiopathic Pulmonary FibrosisThailand, United States, Korea, Republic of, Philippines, Greece, Georgia, Malaysia, Mexico, Chile, Argentina, Colombia, India, South Africa, Romania
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumor | Hematological MalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedPeripheral T-Cell Lymphoma (PTCL)United States
-
Neurotech PharmaceuticalsNot yet recruitingMacular Telangiectasia Type 2United States
-
Fondazione OncotechNot yet recruiting
-
Consorzio OncotechRecruitingOligometastatic Renal Cell CarcinomaItaly
-
Consorzio OncotechCompleted
-
Neurotech PharmaceuticalsCompletedMacular TelangiectasiaUnited States, Australia
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
CureTech LtdCompletedPrimary Mediastinal Large B-Cell Lymphoma | Lymphoma, Large Cell, Diffuse | Lymphoma, Mixed Cell, DiffuseUnited States, Israel, India
-
Acrotech Biopharma Inc.Axis Clinicals LimitedUnknown
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
Consorzio OncotechActive, not recruiting
-
Neurotech PharmaceuticalsCompletedMacular Telangiectasia Type 2United States, Australia, Germany
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
Neurotech PharmaceuticalsTerminated
-
Neurotech PharmaceuticalsCompletedRetinitis PigmentosaUnited States
-
Consorzio OncotechUnknown
-
Consorzio OncotechRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerItaly
-
Consorzio OncotechCompletedMetastatic or Locally Advanced PD-L1 Positive Urothelial CancerItaly
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly